AlphaOS

Coverage building

GNTA has basic price and filing data (45% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.

Deeper coverage nearby

Intelligence coverage: 45%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

GNTA

Genenta Science S.p.A.

Healthcare · Biological Products, (No Diagnostic Substances)

$0.70Sep 29, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for GNTA yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 79d ago

GNTA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on GNTA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Genenta Science S.p.A. (GNTA) — events, not interpretation.

Event
Last session September 29, 2026 at $0.7.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Genenta Science S.p.A. (GNTA)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Genenta Science S.p.A. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biological Products, (No Diagnostic Substances)
Market cap:
$16.48M

GNTA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Genenta Science S.p.A. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.